Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
106-120 of 357
Assessing Nivolumab + Ipilimumab in mNSCLC: 6-Year Outcomes from CheckMate 9LA
Project Oncology®Assessing Nivolumab + Ipilimumab in mNSCLC: 6-Year Outcomes from CheckMate 9LA
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Project Oncology®Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
- advertisement
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Redefining Cancer Care with Functional Precision Medicine
Project Oncology®Redefining Cancer Care with Functional Precision Medicine
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Project Oncology®Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Project Oncology®From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
Project Oncology®Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
- advertisement
Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
Project Oncology®Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Project Oncology®Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
